Tags FDA Approved

FDA Approved

GW Pharmaceuticals reports fiscal third quarter 2018 financial results and operational progress

8/7/18--GW Pharmaceuticals, the world leader in the development and commercialization of cannabinoid prescription medicines, announces financial results for the third quarter, in addition to addressing the significance of FDA approval of Epidiolex®. Read